-- 10,000 participant randomized Phase 2b study will evaluate Gritstone’s self-amplifying mRNA (samRNA) vaccine candidate containing Spike plus other viral targets with an approved vaccine against ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback